Skip to content

Preventing Pneumonia and Other Respiratory Problems in Persons With Spinal Cord Injury

Prevention of Long-Term Respiratory Complications of Spinal Cord Injury: a Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00448045
Enrollment
120
Registered
2007-03-15
Start date
2007-06-30
Completion date
2012-12-31
Last updated
2013-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Spinal cord injuries, Cough, Peak cough flow, Respiratory therapy, Rehabilitation

Brief summary

It is known that individuals with spinal cord injury are at increased risk for respiratory tract infections like pneumonia. Part of this risk is due to weakened chest and abdominal muscles that are vital to deep breathing and the ability to cough. The purpose of this study is to look at the effectiveness of two different treatments in preventing pneumonia and other respiratory problems in persons with SCI. This is a randomized controlled trial investigating the effectiveness of two different treatments. Participants will be randomly assigned to one of the two treatment groups. They will not be told the details of the other intervention since this could influence or change their activities during the study.

Interventions

BEHAVIORALManual and mechanical assisted cough

Individuals will be given a pulse oximeter and taught both manually assisted and mechanically assisted coughing techniques to maximize their cough. Manually assisted coughing consists of air stacking to deep insufflations. An abdominal thrust is then applied upon glottic opening to augment the cough. These subjects will also have rapid access to a mechanical in-exsufflator (CoughAssistTM) and will be trained on how to access and use this device. Mechanically assisted coughing (MAC) involves the use of the CoughAssistTM to expand the lungs and then quickly reverse the pressure to rapidly empty the lungs with expiratory (cough) flows of 600 L/m. An abdominal (manual) thrust is applied in conjunction with the negative pressure (exsufflation) to further increase cough.

BEHAVIORALIncentive spirometry

These individuals will be given a pulse oximeter and an incentive spirometer (AirLife Company) and taught how to use them.

Sponsors

U.S. Department of Education
CollaboratorFED
Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Chronic spinal cord injury that occurred more than 6 months ago * An impaired ability to cough (cough peak flow less than 300 L/min) * Oxygen saturation greater than or equal to 95% when awake and not receiving supplemental oxygen * End-tidal carbon dioxide level less than 43 mm Hg * Without a fever or other signs of an acute illness for the previous 2 weeks * Able to learn the treatment protocol and have someone available at home to assist if needed to help set-up and use the equipment

Exclusion criteria

* Under 18 years of age * Currently have a tracheotomy tube * Have a history of an acute illness in the last 2 weeks * Have lung disease as seen on chest x-ray that results in a baseline oxygen saturation decreasing below 95% during daytime hours and cannot be normalized by usual way of coughing * Already utilizing an oximetry protocol * Have a significant medical complication and psychiatric condition that would interfere with the conduct of the study or interpretation of the study results.

Design outcomes

Primary

MeasureTime frame
Reductions in episodes of community acquired pneumonia (CAP) and related severe respiratory complications3 years

Secondary

MeasureTime frame
Duration of illness and hospitalization3 years
Impact of respiratory complications on quality of life and participation3 years
Reductions in hospitalizations due to a primary diagnosis of a respiratory complications3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026